Example: Heart Attack

Search clinical trials for: Adrecizumab

Total 6 results

  • NCT05156671
    Not yet recruiting
    Adrecizumab (HAM8101) to Improve Prognosis and Outcomes in COVID-19 Trial
    Conditions: COVID-19
  • NCT03989531
    Completed
    Adrecizumab in Cardiogenic Shock
    Conditions: Cardiogenic Shock, Endothelial Dysfunction
  • NCT03085758
    Completed
    Treatment of Patients With Early Septic Shock and Bio-Adrenomedullin(ADM) Concentration > 70 pg/ml With ADRECIZUMAB
    Conditions: Septic Shock
  • NCT04252937
    Recruiting
    Adrecizumab Dose Escalation Safety and Tolerability Evaluation (ADESTE)
    Conditions: Acute Heart Failure
  • NCT03083171
    Completed
    Adrecizumab-LPS Study
    Conditions: Healthy Volunteers
  • NCT02991508
    Completed
    Adrecizumab Phase 1 Trial
    Conditions: Healthy Volunteers

Medical Conditions

Sponsors and Collaborators

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations